rs1671064

Variant summary

Our verdict is Benign. Variant got -14 ACMG points: 0P and 14B. BP4_StrongBP6_ModerateBA1

The NM_001104.4(ACTN3):​c.1568G>A​(p.Arg523Gln) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.555 in 1,608,268 control chromosomes in the GnomAD database, including 252,795 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★). Another nucleotide change resulting in same amino acid change has been previously reported as Likely benignin UniProt. Synonymous variant affecting the same amino acid position (i.e. R523R) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.61 ( 29728 hom., cov: 32)
Exomes 𝑓: 0.55 ( 223067 hom. )

Consequence

ACTN3
NM_001104.4 missense

Scores

1
9

Clinical Significance

Benign criteria provided, single submitter B:1

Conservation

PhyloP100: 7.52
Variant links:
Genes affected
ACTN3 (HGNC:165): (actinin alpha 3) This gene encodes a member of the alpha-actin binding protein gene family. The encoded protein is primarily expressed in skeletal muscle and functions as a structural component of sarcomeric Z line. This protein is involved in crosslinking actin containing thin filaments. An allelic polymorphism in this gene results in both coding and non-coding variants; the reference genome represents the coding allele. The non-functional allele of this gene is associated with elite athlete status. [provided by RefSeq, Feb 2014]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -14 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=9.1066215E-7).
BP6
Variant 11-66560202-G-A is Benign according to our data. Variant chr11-66560202-G-A is described in ClinVar as [Benign]. Clinvar id is 3059413.Status of the report is criteria_provided_single_submitter, 1 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.789 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
ACTN3NM_001104.4 linkuse as main transcriptc.1568G>A p.Arg523Gln missense_variant 14/21 ENST00000513398.2
ACTN3NM_001258371.3 linkuse as main transcriptc.1697G>A p.Arg566Gln missense_variant 14/21

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
ACTN3ENST00000513398.2 linkuse as main transcriptc.1568G>A p.Arg523Gln missense_variant 14/211 NM_001104.4 P1
ENST00000504911.1 linkuse as main transcriptn.183C>T non_coding_transcript_exon_variant 1/23
ACTN3ENST00000502692.5 linkuse as main transcriptc.1697G>A p.Arg566Gln missense_variant 14/212

Frequencies

GnomAD3 genomes
AF:
0.612
AC:
92985
AN:
151952
Hom.:
29675
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.795
Gnomad AMI
AF:
0.434
Gnomad AMR
AF:
0.445
Gnomad ASJ
AF:
0.545
Gnomad EAS
AF:
0.533
Gnomad SAS
AF:
0.415
Gnomad FIN
AF:
0.688
Gnomad MID
AF:
0.579
Gnomad NFE
AF:
0.553
Gnomad OTH
AF:
0.581
GnomAD3 exomes
AF:
0.534
AC:
126656
AN:
237270
Hom.:
35477
AF XY:
0.534
AC XY:
68981
AN XY:
129208
show subpopulations
Gnomad AFR exome
AF:
0.799
Gnomad AMR exome
AF:
0.332
Gnomad ASJ exome
AF:
0.560
Gnomad EAS exome
AF:
0.555
Gnomad SAS exome
AF:
0.421
Gnomad FIN exome
AF:
0.680
Gnomad NFE exome
AF:
0.559
Gnomad OTH exome
AF:
0.527
GnomAD4 exome
AF:
0.549
AC:
799593
AN:
1456200
Hom.:
223067
Cov.:
74
AF XY:
0.547
AC XY:
395601
AN XY:
723868
show subpopulations
Gnomad4 AFR exome
AF:
0.809
Gnomad4 AMR exome
AF:
0.344
Gnomad4 ASJ exome
AF:
0.551
Gnomad4 EAS exome
AF:
0.514
Gnomad4 SAS exome
AF:
0.427
Gnomad4 FIN exome
AF:
0.673
Gnomad4 NFE exome
AF:
0.554
Gnomad4 OTH exome
AF:
0.551
GnomAD4 genome
AF:
0.612
AC:
93085
AN:
152068
Hom.:
29728
Cov.:
32
AF XY:
0.611
AC XY:
45386
AN XY:
74298
show subpopulations
Gnomad4 AFR
AF:
0.796
Gnomad4 AMR
AF:
0.445
Gnomad4 ASJ
AF:
0.545
Gnomad4 EAS
AF:
0.533
Gnomad4 SAS
AF:
0.416
Gnomad4 FIN
AF:
0.688
Gnomad4 NFE
AF:
0.553
Gnomad4 OTH
AF:
0.576
Alfa
AF:
0.569
Hom.:
34417
Bravo
AF:
0.603
TwinsUK
AF:
0.555
AC:
2058
ALSPAC
AF:
0.555
AC:
2140
ESP6500AA
AF:
0.793
AC:
3385
ESP6500EA
AF:
0.553
AC:
4706
ExAC
AF:
0.536
AC:
64730
Asia WGS
AF:
0.497
AC:
1729
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

ACTN3-related disorder Benign:1
Benign, criteria provided, single submitterclinical testingPreventionGenetics, part of Exact SciencesOct 21, 2019This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.061
BayesDel_addAF
Benign
-0.42
T
BayesDel_noAF
Benign
-0.23
CADD
Benign
21
DANN
Benign
0.68
DEOGEN2
Benign
0.21
T;T
FATHMM_MKL
Benign
0.076
N
LIST_S2
Benign
0.66
T;T
MetaRNN
Benign
9.1e-7
T;T
PrimateAI
Uncertain
0.63
T
Sift4G
Benign
1.0
T;T
Polyphen
0.0
.;B
Vest4
0.071
GERP RS
4.8
Varity_R
0.067
gMVP
0.077

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs1671064; hg19: chr11-66327673; COSMIC: COSV59748951; COSMIC: COSV59748951; API